Dihydropyrimidine dehydrogenase (DPD) is the major metabolic enzyme in the
catabolism of 5-fluorouracil, and the activity in normal tissues shows a wi
de variation among individuals. Recent studies demonstrate the relevance of
DPD in the pharmacokinetics, toxicity, and antitumor efficacy of 5-fluorou
racil. We investigated the DPD activity in peripheral blood mononuclear cel
l form 114 healthy subjects in Korea. The DPD activities in healthy volunte
ers were shown to follow a unimodal distribution. The mean of the activity
was 0.28 +/- 0.16 nmol/min/mg protein. A wide (13-fold) intersubject variab
ility was observed (range, 0.06-0.80 nmol/min/mg protein), and, on average,
DPD activity in women (0.26 +/- 0.14) was 13% lower than in men (0.30 +/-
0.16). These findings indicate that the activity of DPD in this study was h
igher than in reports of research with French and white American population
s.